Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name: | Favipiravir | Assay: | 99% |
Standard | Enterprise standard | Appearance: | White Crystalline Powder |
CAS NO | 259793-96-9 | EINECS | 1533716-785-6 |
Minimum order quantity | 500g | Packing: | 1kg/aluminum foil bag; 25kg/drum |
Density | 1.6±0.1 g/cm3 |
---|---|
Boiling Point | 552.6±50.0 °C at 760 mmHg |
Molecular Formula | C5H4FN3O2 |
Molecular Weight | 157.103 |
Flash Point | 288.0±30.1 °C |
Exact Mass | 157.028748 |
PSA | 88.84000 |
LogP | 0.78 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.600 |
Function:
Favipiravir is a broad-spectrum antiviral drug that was cleared by the Drugs Controller General of India (DCGI) last week for "emergency restricted" use among C ovid 19 patients. Glenmark will sell the generic favipiravir under the brand name FabiFlu.
Favipiravir was originally developed in the late 1990s by a company that was later purchased by the Japanese firm Fujifilm as part of its transition from the photo business to healthcare. After being tested against a range of viruses, the drug was approved in Japan in 2014 for emergency use against flu epidemics or to treat new strains of influenza.
Favipiravir, 6-fluoro-3-hydroxypyrazine-2-carboxamide, is a new broad-spectrum antiviral drug targeting RNA-dependent RNA polymerase (RdRp). It was approved for marketing in Japan in March 2014 for the treatment of new and recurrent influenza. During the outbreak of the new coronavirus, the results of the Phase I clinical study of the drug published in March 2020 showed that the drug may have the effect of speeding up virus clearance to alleviate the progress of new coronavirus pneumonia.
Favipiravir can be used for antiviral treatment of influenza A and B. Studies have shown that in addition to influenza virus, the drug also exhibits good antiviral activity against a variety of RNA viruses, such as Ebola virus, arena virus, Bunia virus, and rabies virus.Application:
Favipiravir can be used for antiviral therapy for influenza A and B. Studies have shown that in addition to influenza virus, the drug also shows good antiviral activity against a variety of RNA viruses, such as Ebola virus, arenavirus, Bunya virus, rabies virus, etc.
As a professional health product supplier, we can customize Favipiravir powder with different packing, Favipiravir capusel with different bottles according to your formula and requests.
>Click here to get more information
Fladrafinil | ≥98.0% HPLC | 90212-80-9 |
Picamilon (Sodium) | ≥98%~101%Titration | 62936-56-5 |
Sunifiram | ≥99.5% HPLC | 314728-85-3 |
Unifiram | ≥99.0% HPLC | 272786-64-8 |
Tianeptine acid | ≥99.0% HPLC | 66981-73-5 |
Tianeptine sodium | ≥99.0% HPLC | 30123-17-2 |
Tianeptine Hemisukfate Monohydrate | ≥98.0%~102.0% HPLC | 66981-73-5 |
Galantamine Hydrobromide | ≥99.0% HPLC | 69353-21-5 |
Galanthamine | ≥99.0% HPLC | 357-70-0 |
Huperzine A | ≥1.0% and 99% HPLC | 102518-79-6 |
NSI-189 Freebase | ≥99.0% HPLC | 1270138-40-3 |
NSI-189 Phosphate | ≥99.0% HPLC | 1270138-41-4 |
PRL-8-53 | ≥99.0% HPLC | 51352-87-5 |
agomelatine | ≥99.0% HPLC | 138112-76-2 |
5a hydroxy laxogenin | ≥99.0% HPLC | 56786-63-1 |
Vincamine | ≥99.0% HPLC | 1617-90-9 |
Centrophenoxine | ≥99.0% HPLC | 3685-84-5 |
N-coumaroyldopamine | ≥99.0% HPLC | 103188-46-1 |
N-caffeoyldopamine | ≥99.0% HPLC | 103188-49-4 |
Goods weight |
Packing |
Shipping method |
Lead-time |
1-50kg |
Below 5kg Use Foil bag;5-25kg use two layer PP bag,then into master carton or cardboard drum |
International express |
1~3 days after your payment |
100-200kg |
25kg/drum,use two layer PP bag,then into cardboard drum |
Air shipping Sea Shipping |
3~5 days after your payment |
Over 500kg |
25kg/drum,use two layer PP bag,then into cardboard drum |
Sea shipping |
5~10 days after your payment |
Q1: Can I get some free sample?